ArticleDialogues in health2026
Burden and factors associated with depressive symptoms among adults receiving tuberculosis treatment in South India: A cross-sectional study.
Article in Dialogues in health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Depression is a common but under-recognized comorbidity among persons with tuberculosis (PwTB), adversely affecting treatment adherence, clinical outcomes, and quality of life. This study estimated the prevalence and factors associated with moderate-to-severe depressive symptoms among adults receiving anti-tuberculosis treatment in Bengaluru, India. Methods: We conducted a cross-sectional study between May 2023 and October 2024 among adult PwTB attending tuberculosis units under urban Bengaluru. Participants who had completed the intensive phase of treatment were enrolled using a multistage sampling strategy. Data were collected through structured interviews and review of treatment records. Depressive symptoms were assessed using the Patient Health Questionnaire-9 (PHQ-9). Moderate-to-severe depressive symptoms was defined as PHQ-9 ≥ 10. Logistic regression with cluster-robust standard errors was used to identify associations. Results: Among 200 participants (median age:34 years; 53.5% female), the overall prevalence of moderate-to-severe depressive symptoms was 56.5% (95% CI:50.2-63.1). Moderate depressive symptoms were most common (30.5%), followed by moderately severe (17.5%) and severe depressive symptoms (8.5%). Females had higher prevalence across all severity categories. In adjusted analysis, female gender (aOR 3.2; 95%CI:1.8-12.3), belonging to upper-lower to lower socioeconomic class (aOR 2.5; 95%CI:1.9-6.7), and perceived partial financial dependence (aOR 1.8; 95%CI:1.4-8.1) were associated with moderate-to-severe depressive symptoms. None of the participants had receipt of Conclusion: More than half of PwTB had moderate-to-severe depressive symptoms. Exploratory adjusted analysis suggested associations with gender and socioeconomic vulnerabilities that require confirmation in larger studies. Integrating routine mental health screening, strengthening counselling services, and ensuring social protection support within TB care programs are urgently needed to improve outcomes and advance person-centred TB care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.